Improvement in immune dysfunction after FOLFOX chemotherapy for stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome

2021 ◽  
Author(s):  
Nigel P Murray ◽  
Ricardo Villalon ◽  
Dan Hartmann ◽  
Maria Patricia Rodriguez ◽  
Socrates Aedo
Keyword(s):  
Colon Cancer ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Immune Dysfunction ◽  
Stage Iii ◽  
Stage Iii Colon Cancer ◽  
Folfox Chemotherapy ◽  
Minimal Residual

scholarly journals Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse

2019 ◽  
Vol 13 ◽  
Author(s):  
Nigel P Murray ◽  
Sócrates Aedo ◽  
Ricardo Villalon ◽  
Marco Antonio Lopez ◽  
Simona Minzer ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Stage Iii ◽  
Stage Iii Colon Cancer ◽  
Minimal Residual ◽  
Risk Of Relapse

Eradication of minimal residual disease in the perioperative period in primary colon cancer

2015 ◽  
Vol 4 (4) ◽  
pp. 157-166 ◽  
Author(s):  
Paul H Sugarbaker ◽  
Paolo Sammartino ◽  
Antonios-Apostolos Tentes
Keyword(s):  
Colon Cancer ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Perioperative Period ◽  
Primary Colon Cancer ◽  
Primary Colon ◽  
Minimal Residual

scholarly journals Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

2016 ◽  
Vol 8 (346) ◽  
pp. 346ra92-346ra92 ◽  
Author(s):  
Jeanne Tie ◽  
Yuxuan Wang ◽  
Cristian Tomasetti ◽  
Lu Li ◽  
Simeon Springer ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Minimal Residual Disease ◽  
Dna Analysis ◽  
Residual Disease ◽  
Circulating Tumor Dna ◽  
Stage Ii ◽  
Stage Ii Colon Cancer ◽  
Tumor Dna ◽  
Minimal Residual

Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer

2015 ◽  
Vol 14 (4) ◽  
pp. 262-268.e1 ◽  
Author(s):  
Aalok Kumar ◽  
Renata D. Peixoto ◽  
Hagen F. Kennecke ◽  
Daniel J. Renouf ◽  
Howard J. Lim ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Stage Iii ◽  
Stage Iii Colon Cancer ◽  
Folfox Chemotherapy

4020 POSTER Efficacy and Toxicity of Adjuvant FOLFOX Chemotherapy in Elderly Patients With Stage III Colon Cancer – Single Center Study

2011 ◽  
Vol 47 ◽  
pp. S279
Author(s):  
J.Y. Kim ◽  
Y.J. Kim ◽  
K.W. Lee ◽  
D.W. Kim ◽  
H.S. Lee ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Elderly Patients ◽  
Stage Iii ◽  
Single Center ◽  
Stage Iii Colon Cancer ◽  
Single Center Study ◽  
Folfox Chemotherapy ◽  
Center Study

scholarly journals Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy efficacy and clinical behavior of recurrences

2021 ◽  
pp. clincanres.2404.2021
Author(s):  
Tenna Vesterman Henriksen ◽  
Noelia Tarazona ◽  
Amanda Frydendahl ◽  
Thomas Reinert ◽  
Francisco Gimeno-Valiente ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Adjuvant Therapy ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Circulating Tumor Dna ◽  
Stage Iii ◽  
Clinical Behavior ◽  
Therapy Efficacy ◽  
Tumor Dna ◽  
Minimal Residual

scholarly journals Cytokeratin 18 (CK18) and CK18 Fragments for Detection of Minimal Residual Disease in Colon Cancer Patients

10.5772/33557 ◽  
2012 ◽  
Author(s):  
Ulrike Olszewski-Hamilton ◽  
Veronika Buxhofer-Ausch ◽  
Christoph Ausch ◽  
Gerhard Hamilto
Keyword(s):  
Colon Cancer ◽  
Cancer Patients ◽  
Minimal Residual Disease ◽  
Residual Disease ◽  
Cytokeratin 18 ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document